Episode

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

Podcast: Oncology Today with Dr Neil Love
Published: May 15, 2026
Duration seconds: 3115
Processing state: not_requested
Canonical source: https://oncologytoday.captivate.fm/episode/6049-oncologytodayparpprostate26
Audio: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/db44f335-d209-45a1-900c-a3cb0b244dbb.mp3
JSON: /v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/parp-inhibitors-for-patients-with-hormone-sensitive-and-castration-resistant-metastatic-prostate-cancer-an-interview-with-dr-wassim-abida
Markdown: /podcast/oncology-today-with-dr-neil-love-1004241/parp-inhibitors-for-patients-with-hormone-sensitive-and-castration-resistant-metastatic-prostate-cancer-an-interview-with-dr-wassim-abida.md

Actions

POST https://stenobird.com/v1/public/podcasts/oncology-today-with-dr-neil-love-1004241/episodes/parp-inhibitors-for-patients-with-hormone-sensitive-and-castration-resistant-metastatic-prostate-cancer-an-interview-with-dr-wassim-abida/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/oncology-today-with-dr-neil-love-1004241/parp-inhibitors-for-patients-with-hormone-sensitive-and-castration-resistant-metastatic-prostate-cancer-an-interview-with-dr-wassim-abida.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer. CME information and select publications here .